2Geerts WH,Heit JA,Clagett GP,et al.Prevention of venous thromboembolism[J].Cbest 2001,119(Suppl):S132-S175.
3Horie H,Endo N,Sata N,et al.Postoperative venous thrombosis in genera surgery patients and perioperative prophylaxis[J].Nippon Geka Gakkai Zasshi.2005,106(3):232-236.
4Anon.Prevention of fatal postoperative pulmonary embolism by low doses of heparin.An international multicentre trial[J].Lancet 1975,ii:45-51.
6Lee AY,Levine MN.Management of venous thrombembolism in cancer patients[J].Oncology,2000,14(3):409.
7Weitz JI.Low-molecular-weight heparins[J].N Engl J Med 1997,337:688-698.
8Zacharski LR,Prandoni P,Monreal M.Warfarin versus low-molecular-weight heparin therapy in cancer patients[J].Oncologist.2005,10(1):72-79.
9Sasahara AA,Koppenhagen K,Haring R,et al.Low molecular weight heparin plus dihydroergotamine for prophylaxis of postoperative deep vein thrombosis[J].Br J Surg 1986,73:697-700.
10Kakkar VV,Boeckl O,Boneu B,et al.Efficacy and safety of a low-molecular-weight heparin and standard unfractionated heparin for prophylaxis of postoperative venous thromboembolism[J]:European multicentre trial.World J Surg 1997,21:2-9.
